AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Insider Transactions Reported | Illumina(ILMN)saw insider trading activity on 7/8/2025
ByAinvest
Tuesday, Jul 8, 2025 10:00 pm ET1min read
Illumina(ILMN) saw insider trading activity on 7/8/2025, there was 1 insider trade during the day.
【History Insider Transaction】
| Declare date | Position | Name | Buy/Sell | Quantity | Price per share/USD | Total Amount/USD |
|---|---|---|---|---|---|---|
| 7/8/2025 | SVP, Chief Commercial Officer | Cunningham Everett | Sell | 4248 | 97.15 | 412.69k |
| 7/2/2025 | -- | Ullem Scott B. | Buy | 307 | 81.20 | 24.93k |
| 5/20/2025 | -- | DORSA CAROLINE、Ullem Scott B. | Sell | 2140 | 83.62 | 178.95k |
| 5/14/2025 | Chief Executive Officer | Thaysen Jacob | Buy | 3700 | 80.92 | 299.4k |
| 5/14/2025 | Chief Executive Officer | Thaysen Jacob | Buy | 1200 | 79.70 | 95.64k |
| 5/14/2025 | Chief Executive Officer | Thaysen Jacob | Buy | 4946 | 80.70 | 399.14k |
| 5/14/2025 | Chief Executive Officer | Thaysen Jacob | Buy | 200 | 82.66 | 16.53k |
| 5/14/2025 | Chief Executive Officer | Thaysen Jacob | Buy | 804 | 81.56 | 65.57k |
| 5/14/2025 | Chief Executive Officer | Thaysen Jacob | Buy | 1400 | 81.54 | 114.16k |
| 5/14/2025 | Chief Executive Officer | Thaysen Jacob | Buy | 100 | 82.26 | 8.23k |
[Company Profile]
Illumina, Inc. is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. The company was incorporated in California in April 1998 and reincorporated in Delaware in July 2000. Using its proprietary technologies, the company provide a comprehensive line of genetic analysis solutions, with products and services that serve a broad range of highly interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. The company's customers include leading genomic research centers, academic institutions, government laboratories, and clinical research organizations, as well as pharmaceutical, biotechnology, agrigenomics, and consumer genomics companies.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet